Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)Retained EarningsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pharming (PHAR) Non-Current Debt (2019 - 2021)

Historic Non-Current Debt for Pharming (PHAR) over the last 3 years, with Q4 2021 value amounting to $165000.0.

  • Pharming's Non-Current Debt fell 2000.63% to $165000.0 in Q4 2021 from the same period last year, while for Dec 2021 it was $165000.0, marking a year-over-year decrease of 2000.63%. This contributed to the annual value of $165000.0 for FY2021, which is 2216.98% down from last year.
  • According to the latest figures from Q4 2021, Pharming's Non-Current Debt is $165000.0, which was down 2000.63% from $206266.1 recorded in Q4 2020.
  • In the past 5 years, Pharming's Non-Current Debt registered a high of $19.1 million during Q4 2019, and its lowest value of $165000.0 during Q4 2021.
  • Over the past 3 years, Pharming's median Non-Current Debt value was $206266.1 (recorded in 2020), while the average stood at $6.5 million.
  • Per our database at Business Quant, Pharming's Non-Current Debt tumbled by 9892.17% in 2020 and then plummeted by 2000.63% in 2021.
  • Pharming's Non-Current Debt (Quarter) stood at $19.1 million in 2019, then crashed by 98.92% to $206266.1 in 2020, then decreased by 20.01% to $165000.0 in 2021.
  • Its Non-Current Debt stands at $165000.0 for Q4 2021, versus $206266.1 for Q4 2020 and $19.1 million for Q4 2019.